Ticker Report TD Asset Management Inc boosted its holdings in NovoCure Limited (NASDAQ:NVCR - Free Report) by 4.7% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 294,752...\n more…
Business Wire Novocure (NASDAQ: NVCR) announced today it will present a real-world analysis of usage of its Tumor Treating Fields (TTFields) therapy and survival outcomes in newly diagnosed glioblastoma (ndGBM...\n more…
Fool.com Headlines A series of C-suite changes negatively affected the share price of cancer-focused biotech NovoCure (NASDAQ: NVCR) across the holiday-shortened trading week. When the smoke cleared, the company's...\n more…